Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Chem Commun (Camb) ; 54(73): 10248-10251, 2018 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-30091759

RESUMO

The dynamic interactions of an individual matrix metalloproteinase-1 were imaged and monitored in the presence of either triple-helical or non-triple-helical, partially structured collagen-mimic substrates. The enzyme exhibited ten-fold increased catalytic turnover rates with the structurally modified substrate by skipping the triple-helix unwinding step during the catalytic pathway.


Assuntos
Colágeno/metabolismo , Metaloproteinase 1 da Matriz/metabolismo , Mimetismo Molecular , Catálise , Colágeno/química , Cristalografia por Raios X , Cinética , Metaloproteinase 1 da Matriz/química , Microscopia de Força Atômica , Conformação Proteica , Especificidade por Substrato
2.
Mol Pharm ; 14(6): 1916-1928, 2017 06 05.
Artigo em Inglês | MEDLINE | ID: mdl-28493710

RESUMO

Improving the therapeutic index of anticancer agents is an enormous challenge. Targeting decreases the side effects of the therapeutic agents by delivering the drugs to the intended destination. Nanocarriers containing the nuclear localizing peptide sequences (NLS) translocate to the cell nuclei. However, the nuclear localization peptides are nonselective and cannot distinguish the malignant cells from the healthy counterparts. In this study, we designed a "masked" NLS peptide which is activated only in the presence of overexpressed matrix metalloproteinase-7 (MMP-7) enzyme in the pancreatic cancer microenvironment. This peptide is conjugated to the surface of redox responsive polymersomes to deliver doxorubicin and curcumin to the pancreatic cancer cell nucleus. We have tested the formulation in both two- and three-dimensional cultures of pancreatic cancer and normal cells. Our studies revealed that the drug-encapsulated polymeric vesicles are significantly more toxic toward the cancer cells (shrinking the spheroids up to 49%) compared to the normal cells (shrinking the spheroids up to 24%). This study can lead to the development of other organelle targeted drug delivery systems for various human malignancies.


Assuntos
Antineoplásicos/administração & dosagem , Antineoplásicos/metabolismo , Curcumina/administração & dosagem , Curcumina/farmacologia , Doxorrubicina/administração & dosagem , Sistemas de Liberação de Medicamentos/métodos , Neoplasias Pancreáticas/metabolismo , Peptídeos/química , Polímeros/química , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Doxorrubicina/farmacologia , Humanos , Metaloproteinase 1 da Matriz/metabolismo , Metaloproteinase 7 da Matriz/metabolismo , Microscopia de Força Atômica , Oxirredução/efeitos dos fármacos
3.
Bioconjug Chem ; 27(3): 762-71, 2016 Mar 16.
Artigo em Inglês | MEDLINE | ID: mdl-26848507

RESUMO

Considering the systemic toxicity of chemotherapeutic agents, there is an urgent need to develop new targeted drug delivery systems. Herein, we have developed a new nuclear targeted, redox sensitive, drug delivery vehicle to simultaneously deliver the anticancer drugs gemcitabine and doxorubicin to the nuclei of pancreatic cancer cells. We prepared polymeric bilayer vesicles (polymersomes), and actively encapsulated the drug combination by the pH gradient method. A redox-sensitive polymer (PEG-S-S-PLA) was incorporated to sensitize the formulation to reducing agent concentration. Acridine orange (AO) was conjugated to the surface of the polymersomes imparting nuclear localizing property. The polymersomes' toxicity and efficacy were compared with those of a free drug combination using monolayer and three-dimensional spheroid cultures of pancreatic cancer cells. We observed that the redox sensitive, nuclear-targeted polymersomes released more than 60% of their encapsulated contents in response to 50 mM glutathione. The nanoparticles are nontoxic; however, the drug encapsulated vesicles have significant toxicity. The prepared formulation can increase the drug's therapeutic index by delivering the drugs directly to the cells' nuclei, one of the key organelles in the cells. This study is likely to initiate research in targeted nuclear delivery using other drug formulations in other types of cancers.


Assuntos
Laranja de Acridina/química , Antineoplásicos/administração & dosagem , Núcleo Celular/metabolismo , Desoxicitidina/análogos & derivados , Doxorrubicina/administração & dosagem , Neoplasias Pancreáticas/patologia , Polímeros/química , Linhagem Celular Tumoral , Desoxicitidina/administração & dosagem , Humanos , Microscopia Eletrônica de Transmissão , Gencitabina
4.
Ther Deliv ; 6(4): 521-34, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25996048

RESUMO

Polymersomes are stable vesicles prepared from amphiphilic polymers and are more stable compared with liposomes. Although these nanovesicles have many attractive properties for in vitro/in vivo applications, liposome-based drug delivery systems are still prevalent in the market. In order to expedite the translational potential and to provide medically valuable formulations, the polymersomes need to be biocompatible and biodegradable. In this review, recent developments for biocompatible and biodegradable polymersomes, including the design of intelligent, targeted, and stimuli-responsive vesicles are summarized.


Assuntos
Sistemas de Liberação de Medicamentos/métodos , Nanosferas/administração & dosagem , Nanosferas/química , Neoplasias/tratamento farmacológico , Preparações Farmacêuticas/administração & dosagem , Polímeros/administração & dosagem , Polímeros/química , Humanos , Modelos Biológicos , Terapia de Alvo Molecular/métodos , Polímeros/síntese química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA